H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 60 Citations 14,771 258 World Ranking 1696 National Ranking 843
Medicine D-index 73 Citations 22,055 377 World Ranking 13347 National Ranking 7023

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Immune system

Evan M. Hersh mainly investigates Internal medicine, Surgery, Immunology, Melanoma and Gastroenterology. His Internal medicine study frequently draws connections to other fields, such as Oncology. As a part of the same scientific family, Evan M. Hersh mostly works in the field of Surgery, focusing on Immunocompetence and, on occasion, Depression, Halothane, Anesthetic, Immunosuppression and Peripheral blood lymphocyte.

His Immunology study combines topics in areas such as Peripheral blood mononuclear cell and In vitro. His studies deal with areas such as Pathology, Toxicity, Neuroblastoma, Stage and Immunotherapy as well as Melanoma. The study incorporates disciplines such as Combination chemotherapy, Cancer, Treatment factors, Morphologic diagnosis and Acute leukemia in addition to Gastroenterology.

His most cited work include:

  • A new type of synthetic peptide library for identifying ligand-binding activity (1864 citations)
  • Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome (873 citations)
  • Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group (523 citations)

What are the main themes of his work throughout his whole career to date?

Evan M. Hersh spends much of his time researching Immunology, Internal medicine, Antigen, Immunotherapy and Melanoma. His Immunology research incorporates themes from Cancer and In vitro. His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Vincristine.

The concepts of his Antigen study are interwoven with issues in Molecular biology, Stimulation and Immunity. Evan M. Hersh has researched Immunotherapy in several fields, including Adjuvant, Colorectal cancer, Immunocompetence and BCG vaccine. His Melanoma research includes themes of Stage, Toxicity and Pathology.

He most often published in these fields:

  • Immunology (43.90%)
  • Internal medicine (26.48%)
  • Antigen (21.25%)

What were the highlights of his more recent work (between 1994-2020)?

  • Melanoma (18.82%)
  • Internal medicine (26.48%)
  • Cancer research (9.06%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Melanoma, Internal medicine, Cancer research, Immunology and Imexon. His Melanoma study incorporates themes from Brain metastasis, Phases of clinical research, Genetic enhancement, Stage and Breast cancer. The various areas that he examines in his Internal medicine study include Gastroenterology, Surgery and Oncology.

His research investigates the link between Immunology and topics such as Histamine that cross with problems in Survival rate. His Imexon study combines topics from a wide range of disciplines, such as Glutathione and Pharmacology. His research in Antigen intersects with topics in Immune system and B cell.

Between 1994 and 2020, his most popular works were:

  • Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group (523 citations)
  • Phase I/II study of ipilimumab for patients with metastatic melanoma (364 citations)
  • Local drug and gene delivery through microbubbles (252 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Immune system

His primary scientific interests are in Melanoma, Internal medicine, Surgery, Gastroenterology and Cancer research. His Melanoma research is multidisciplinary, incorporating elements of Cytokine, Adverse effect, Group B, Toxicity and Immunotherapy. When carried out as part of a general Surgery research project, his work on Chemotherapy is frequently linked to work in In patient, therefore connecting diverse disciplines of study.

Evan M. Hersh has included themes like Cancer, Pharmacokinetics, Dosing, Stage and Ipilimumab in his Gastroenterology study. The Cancer research study combines topics in areas such as Mammary tumor, Transforming growth factor, Antigen, B cell and Tumor progression. Antigen is a primary field of his research addressed under Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A new type of synthetic peptide library for identifying ligand-binding activity

Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby.
Nature (1992)

2465 Citations

Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams.
The New England Journal of Medicine (1984)

1393 Citations

Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh.
The New England Journal of Medicine (1984)

957 Citations

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap.
Annals of Internal Medicine (1980)

742 Citations

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Agop Y. Bedikian;Michael Millward;Hubert Pehamberger;Robert Conry.
Journal of Clinical Oncology (2006)

713 Citations

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta.
The Journal of Infectious Diseases (1985)

517 Citations

Phase I/II study of ipilimumab for patients with metastatic melanoma

Jeffrey S. Weber;Steven O’Day;Walter Urba;John Powderly.
Journal of Clinical Oncology (2008)

488 Citations

Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Evan M. Hersh;Joost J. Oppenheim.
The New England Journal of Medicine (1965)

487 Citations

Local drug and gene delivery through microbubbles

Evan C Unger;Evan Hersh;Mani Vannan;Terry O Matsunaga.
Progress in Cardiovascular Diseases (2001)

399 Citations

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

G. Lopez-Berestein;R. Mehta;R. L. Hopfer;K. Mills.
The Journal of Infectious Diseases (1983)

374 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Evan M. Hersh

Kit S. Lam

Kit S. Lam

University of California, Davis

Publications: 140

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 76

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 60

Jordan U. Gutterman

Jordan U. Gutterman

The University of Texas MD Anderson Cancer Center

Publications: 52

Aman U. Buzdar

Aman U. Buzdar

The University of Texas at Austin

Publications: 42

Donald L. Morton

Donald L. Morton

Saint John's Health Center

Publications: 42

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 42

Svetomir N. Markovic

Svetomir N. Markovic

Mayo Clinic

Publications: 41

Thomas Kodadek

Thomas Kodadek

Scripps Research Institute

Publications: 41

Emil J. Freireich

Emil J. Freireich

The University of Texas System

Publications: 40

Gerald P. Bodey

Gerald P. Bodey

The University of Texas MD Anderson Cancer Center

Publications: 40

John M. Kirkwood

John M. Kirkwood

University of Pittsburgh

Publications: 36

Dehua Pei

Dehua Pei

The Ohio State University

Publications: 35

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 35

Ernest C. Borden

Ernest C. Borden

Cleveland Clinic

Publications: 34

Richard A. Houghten

Richard A. Houghten

Torrey Pines Institute For Molecular Studies

Publications: 33

Something went wrong. Please try again later.